Medtronic PLC Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares fell 1.89% to $91.14 on Tuesday, underperforming the broader market and key competitors like Johnson & Johnson and Danaher Corp. This marks the second consecutive day of losses for Medtronic, which remains 14.29% below its 52-week high. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) slid 1.89% to $91.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.32% to 7,677.28 and the Dow Jones Industrial Average rising 0.30% to 53,577.40.
This was the stock's second consecutive day of losses.
Medtronic PLC closed 14.29% short of its 52-week high of $106.33, which the company reached on November 26th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.53% to $273.14, Danaher Corp. (DHR) rose 0.40% to $215.97, and Abbott Laboratories (ABT) fell 0.46% to $116.13.
Trading volume (6.8 M) remained 1.2 million below its 50-day average volume of 8.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-25-26 1640ET